vs

Side-by-side financial comparison of Bowhead Specialty Holdings Inc. (BOW) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $151.7M, roughly 1.5× Bowhead Specialty Holdings Inc.). Bowhead Specialty Holdings Inc. runs the higher net margin — 9.8% vs 5.8%, a 4.0% gap on every dollar of revenue. Bowhead Specialty Holdings Inc. produced more free cash flow last quarter ($326.0M vs $-19.2M).

Bowhead Specialty Holdings Inc. is a specialty insurance holding company that offers a diversified portfolio of property and casualty insurance products, focusing on underserved niche market segments primarily across North America. It provides tailored risk management solutions and specialized coverage options for both commercial and individual clients.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

BOW vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.5× larger
UTI
$220.8M
$151.7M
BOW
Higher net margin
BOW
BOW
4.0% more per $
BOW
9.8%
5.8%
UTI
More free cash flow
BOW
BOW
$345.2M more FCF
BOW
$326.0M
$-19.2M
UTI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BOW
BOW
UTI
UTI
Revenue
$151.7M
$220.8M
Net Profit
$14.8M
$12.8M
Gross Margin
Operating Margin
11.7%
7.1%
Net Margin
9.8%
5.8%
Revenue YoY
9.6%
Net Profit YoY
-42.1%
EPS (diluted)
$0.44
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOW
BOW
UTI
UTI
Q4 25
$151.7M
$220.8M
Q3 25
$143.9M
$222.4M
Q2 25
$133.3M
$204.3M
Q1 25
$122.7M
$207.4M
Q4 24
$201.4M
Q3 24
$116.8M
$196.4M
Q2 24
$98.9M
$177.5M
Q1 24
$184.2M
Net Profit
BOW
BOW
UTI
UTI
Q4 25
$14.8M
$12.8M
Q3 25
$15.2M
$18.8M
Q2 25
$12.3M
$10.7M
Q1 25
$11.4M
$11.4M
Q4 24
$22.2M
Q3 24
$12.1M
$18.8M
Q2 24
$5.5M
$5.0M
Q1 24
$7.8M
Operating Margin
BOW
BOW
UTI
UTI
Q4 25
11.7%
7.1%
Q3 25
13.3%
11.2%
Q2 25
11.9%
6.9%
Q1 25
11.8%
8.1%
Q4 24
13.6%
Q3 24
13.5%
13.3%
Q2 24
7.5%
4.2%
Q1 24
6.1%
Net Margin
BOW
BOW
UTI
UTI
Q4 25
9.8%
5.8%
Q3 25
10.5%
8.4%
Q2 25
9.3%
5.2%
Q1 25
9.3%
5.5%
Q4 24
11.0%
Q3 24
10.4%
9.6%
Q2 24
5.6%
2.8%
Q1 24
4.2%
EPS (diluted)
BOW
BOW
UTI
UTI
Q4 25
$0.44
$0.23
Q3 25
$0.45
$0.33
Q2 25
$0.36
$0.19
Q1 25
$0.34
$0.21
Q4 24
$0.40
Q3 24
$0.36
$0.35
Q2 24
$0.20
$0.09
Q1 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOW
BOW
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$193.5M
$162.8M
Total DebtLower is stronger
$146.4M
$101.4M
Stockholders' EquityBook value
$448.3M
$335.9M
Total Assets
$2.4B
$834.0M
Debt / EquityLower = less leverage
0.33×
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOW
BOW
UTI
UTI
Q4 25
$193.5M
$162.8M
Q3 25
$197.9M
$169.1M
Q2 25
$114.8M
$70.7M
Q1 25
$88.0M
$96.0M
Q4 24
$172.0M
Q3 24
$132.9M
$161.9M
Q2 24
$180.3M
$115.5M
Q1 24
$116.1M
Total Debt
BOW
BOW
UTI
UTI
Q4 25
$146.4M
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Q1 24
$141.9M
Stockholders' Equity
BOW
BOW
UTI
UTI
Q4 25
$448.3M
$335.9M
Q3 25
$430.2M
$328.1M
Q2 25
$407.2M
$306.8M
Q1 25
$391.0M
$293.9M
Q4 24
$280.0M
Q3 24
$364.7M
$260.2M
Q2 24
$339.9M
$239.4M
Q1 24
$232.6M
Total Assets
BOW
BOW
UTI
UTI
Q4 25
$2.4B
$834.0M
Q3 25
$2.1B
$826.1M
Q2 25
$1.9B
$740.8M
Q1 25
$1.8B
$720.4M
Q4 24
$753.8M
Q3 24
$1.5B
$744.6M
Q2 24
$1.4B
$706.0M
Q1 24
$702.1M
Debt / Equity
BOW
BOW
UTI
UTI
Q4 25
0.33×
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOW
BOW
UTI
UTI
Operating Cash FlowLast quarter
$331.6M
$3.1M
Free Cash FlowOCF − Capex
$326.0M
$-19.2M
FCF MarginFCF / Revenue
214.9%
-8.7%
Capex IntensityCapex / Revenue
3.7%
10.1%
Cash ConversionOCF / Net Profit
22.34×
0.24×
TTM Free Cash FlowTrailing 4 quarters
$593.4M
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOW
BOW
UTI
UTI
Q4 25
$331.6M
$3.1M
Q3 25
$114.7M
$57.1M
Q2 25
$109.0M
$18.1M
Q1 25
$47.7M
$-789.0K
Q4 24
$23.0M
Q3 24
$119.4M
$67.5M
Q2 24
$10.0M
Q1 24
$-2.5M
Free Cash Flow
BOW
BOW
UTI
UTI
Q4 25
$326.0M
$-19.2M
Q3 25
$113.5M
$40.6M
Q2 25
$107.4M
$6.8M
Q1 25
$46.5M
$-11.7M
Q4 24
$19.6M
Q3 24
$118.4M
$60.0M
Q2 24
$3.0M
Q1 24
$-8.4M
FCF Margin
BOW
BOW
UTI
UTI
Q4 25
214.9%
-8.7%
Q3 25
78.8%
18.3%
Q2 25
80.6%
3.4%
Q1 25
37.9%
-5.7%
Q4 24
9.7%
Q3 24
101.4%
30.6%
Q2 24
1.7%
Q1 24
-4.6%
Capex Intensity
BOW
BOW
UTI
UTI
Q4 25
3.7%
10.1%
Q3 25
0.9%
7.4%
Q2 25
1.2%
5.5%
Q1 25
1.0%
5.3%
Q4 24
1.7%
Q3 24
0.9%
3.8%
Q2 24
4.0%
Q1 24
3.2%
Cash Conversion
BOW
BOW
UTI
UTI
Q4 25
22.34×
0.24×
Q3 25
7.56×
3.04×
Q2 25
8.83×
1.69×
Q1 25
4.18×
-0.07×
Q4 24
1.04×
Q3 24
9.88×
3.58×
Q2 24
2.01×
Q1 24
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BOW
BOW

Segment breakdown not available.

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons